Skip to Content

LCI 1477 (Diethylpropion Hydrochloride Extended Release 75 mg)

Pill with imprint LCI 1477 is White, Capsule-shape and has been identified as Diethylpropion hydrochloride extended release 75 mg. It is supplied by Lannett Company, Inc..

Diethylpropion is used in the treatment of obesity and belongs to the drug classes anorexiants, CNS stimulants. There is no proven risk in humans during pregnancy. Diethylpropion 75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for LCI 1477

Diethylpropion hydrochloride extended release

LCI 1477
75 mg
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
4 - Some potential for abuse
Labeler / Supplier:
Lannett Company, Inc.
Inactive Ingredients:
carbomer homopolymer type A
tartaric acid
hypromellose acetate succinate 06081224 (3 mm2/s)
povidone k30
magnesium stearate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.